16
Participants
Start Date
December 31, 2004
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
NCPAP; Nasal continuous positive airway pressure.
Patients will be randomized to receive either therapeutic or sub-therapeutic NCPAP; Nasal continuous positive airway pressure treatment. In patients randomized to therapeutic NCPAP, treatment pressures will be increased until apneas and hypopneas are prevented during all sleep stages. In the sub-therapeutic treatment group, pressure will be left unchanged at the lowest possible value for the NCPAP device. Pressure settings for NCPAP therapy will be determined by Dr. J. Leech, collaborator and specialist in sleep disorders. Treatment will be continued for a total of 6 weeks.
NCPAP Nasal Continuous Positive Airway Pressure-sub-therapeutic treatment group
In the sub-therapeutic treatment group, pressure will be left unchanged at the lowest possible value for the NCPAP device. Pressure settings for NCPAP therapy will be determined by Dr. J. Leech, collaborator and specialist in sleep disorders. Treatment will be continued for a total of 6 weeks.
The Ottawa Hospital, Ottawa
Lead Sponsor
Ottawa Hospital Research Institute
OTHER